Live feed08:13:00·39dPRReleasevia QuantisnowHoth Therapeutics Reports Positive HT-001 PK, Safety, and Clinical Activity Data in Cancer Patients with EGFR Therapy-Associated Skin Toxicities Showing ~77% Increase in Drug Exposure and Minimal Systemic AbsorptionByQuantisnow·Wall Street's wire, on your screen.HOTH· Hoth Therapeutics Inc.Health Care
